Prolanta was originally developed to treat breast cancer, but breast cancer is far too expensive to run trials on. They went with ovarian cancer first because they save money due to the orphan drug designation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.